Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
416,598,522
-
Total 13F shares
-
146,128,655
-
Share change
-
+40,208,551
-
Total reported value
-
$407,670,376
-
Put/Call ratio
-
61%
-
Price per share
-
$2.79
-
Number of holders
-
197
-
Value change
-
+$107,801,104
-
Number of buys
-
118
-
Number of sells
-
85
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q2 2025
As of 30 Jun 2025,
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by
197 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
146,128,655 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, PNC Financial Services Group, Inc., BANK OF AMERICA CORP /DE/, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, CITADEL ADVISORS LLC, and MARSHALL WACE, LLP.
This page lists
197
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.